About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalNJ, NY, PA
Clinical Trials (13)
View allTotal Trials
13
As Lead Sponsor
11
As Collaborator
2
Total Enrollment
1,583
By Phase
PHASE2: 6EARLY_PHASE1: 1PHASE1: 1PHASE2/PHASE3: 3PHASE3: 1
By Status
COMPLETED: 12ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline13 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06245213Lead Sponsor
A Study of ANAVEX3-71 in Adults With Schizophrenia
PHASE2Active, not recruiting
71 participants
Started: Mar 15, 2024 · Completed: Jun 30, 2025
NCT04928703Collaborator
Effects of Ketamine on ERP/EEG Measures in Healthy Volunteers
EARLY_PHASE1Completed
33 participants
Started: May 26, 2022 · Completed: Dec 12, 2022
NCT04442945Lead Sponsor
Phase 1 Study of ANAVEX3-71
PHASE1Completed
36 participants
Started: Jul 3, 2020 · Completed: Oct 30, 2021
NCT04304482Lead Sponsor
ANAVEX2-73 Study in Pediatric Patients With Rett Syndrome
PHASE2/PHASE3Completed
92 participants
Started: Jul 1, 2020 · Completed: Jun 30, 2023
NCT04314934Lead Sponsor
OLE of Phase 2b/3 Study ANAVEX2-73-AD-004
PHASE2/PHASE3Completed
300 participants
Started: Oct 10, 2019 · Completed: Jun 14, 2024
Locations (1)
Headquarters
New York, NY, United States
Map
Loading map...